Gentamicin treatment in McArdle disease : Failure to correct myophosphorylase deficiency

Saved in:

Bibliographic Details
Published in:	Neurology Vol. 66; no. 2; pp. 285 - 286
Main Authors:	SCHROERS, A, KLEY, R. A, STACHON, A, HORVATH, R, LOCHMÜLLER, H, ZANGE, J, VORGERD, M
Format:	Journal Article
Language:	English
Published:	Hagerstown, MD Lippincott Williams & Wilkins 24-01-2006
Subjects:	Adolescent Adult Biological and medical sciences Cells, Cultured Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Energy Metabolism Female Gentamicins - administration & dosage Gentamicins - pharmacology Gentamicins - therapeutic use Glycogen Phosphorylase, Muscle Form - deficiency Glycogen Phosphorylase, Muscle Form - genetics Glycogen Phosphorylase, Muscle Form - metabolism Glycogen Storage Disease Type V - drug therapy Glycogen Storage Disease Type V - enzymology Glycogen Storage Disease Type V - genetics Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Magnetic Resonance Spectroscopy Male Medical sciences Middle Aged Muscle, Skeletal - enzymology Mutation Myoblasts - drug effects Myoblasts - enzymology Nervous system (semeiology, syndromes) Neurology Osmolar Concentration Phosphorylases - metabolism Nervous system diseases Treatment Glycogenosis V Mac Ardle Deficiency Gentamicin Metabolic diseases Carbohydrate Enzymopathy Genetic disease
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0028-3878 1526-632X
DOI:	10.1212/01.wnl.0000194212.31318.fc